据欧盟食品安全局消息，7月28日欧盟食品安全局发布了发酵大豆提取物NSK-SDportant; font: 14px/19px Verdana, Helvetica, Arial, sans-serif; white-space: normal; float: none; letter-spacing: normal; color: rgb(103,103,103); word-spacing: 0px; -webkit-text-stroke-width: 0px">® 作为新资源食品的安全性。
发酵大豆提取物NSK-SD?经过标准处理后纳豆激酶酶活性为20,000-28,000纤维蛋白降解单位/克。欧盟评估小组认为发酵大豆提取物NSK-SDportant; font: 14px/19px Verdana, Helvetica, Arial, sans-serif; white-space: normal; float: none; letter-spacing: normal; color: rgb(103,103,103); word-spacing: 0px; -webkit-text-stroke-width: 0px">® 的产品说明、批次差异性以及稳定性较好不存在安全隐患。作为膳食补充剂每天的限量为100mgNSK-SDportant; font: 14px/19px Verdana, Helvetica, Arial, sans-serif; white-space: normal; float: none; letter-spacing: normal; color: rgb(103,103,103); word-spacing: 0px; -webkit-text-stroke-width: 0px">® ，适宜人群为35岁以上健康人群，孕妇和哺乳期妇女除外。
部分原文报道如下：
Following a request from the European Commission, the EFSA Panel on Dietetic Products, Nutrition and Allergies （NDA） was asked to deliver an opinion on the fermented soybean extract NSK-SD? as a novel food （NF） submitted pursuant to Regulation （EC） No 258/97 of the European Parliament and of the Council, taking into account the comments and objections of a scientific nature raised by Member States. The NF is the fermented soybean extract NSK-SD?, which is standardised to a nattokinase enzyme activity of 20,000-28,000 fibrin degradation units/g.
原文链接：<http://www.efsa.europa.eu/en/efsajournal/pub/4541>
日期：2016-08-01
